Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.

To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download Primary myelofibrosis (PMF) is a Ph-negative myeloproliferative neoplasm (MPN), characterized by advanced bone marrow...

Full description

Bibliographic Details
Published in:Journal of Cellular and Molecular Medicine
Main Authors: Teodorescu, Patric, Pasca, Sergiu, Jurj, Ancuta, Gafencu, Grigore, Joelsson, Jon-Petur, Selicean, Sonia, Moldovan, Cristian, Munteanu, Raluca, Onaciu, Anca, Tigu, Adrian-Bogdan, Buse, Mihail, Zimta, Alina-Andreea, Stiufiuc, Rares, Petrushev, Bobe, Desmirean, Minodora, Dima, Delia, Vlad, Cristina, Bergthorsson, Jon Thor, Berce, Cristian, Ciurea, Stefan, Ghiaur, Gabriel, Tomuleasa, Ciprian
Other Authors: 1Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 2Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania. 3Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 4Molecular Haematology Unit - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. 5Stem Cell Research Unit, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland. 6Department of Laboratory Hematology, Landspitali University Hospital, Reykjavík, Iceland. 7Graduate School for Cellular and Biomedical Sciences, Universität Bern, Bern, Switzerland. 8Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 9Department of Pathology, Constantin Papilian Military Hospital, Cluj Napoca, Romania. 10Department of Hematology, Ion Chiricuta Clinical Research Center, Cluj Napoca, Romania. 11Department of Cardiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 12Department of Cardiology, Rehabilitation Hospital, Cluj Napoca, Romania. 13Department of Laboratory Hematology, Landspitali, University Hospital, Reykjavík, Iceland. 14Animal Facility, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 15Department of Cellular Therapies and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA. 16Department of Leukemia, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2020
Subjects:
Online Access:http://hdl.handle.net/2336/621564
https://doi.org/10.1111/jcmm.15526
id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/621564
record_format openpolar
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language English
topic TGF-β
fibroblast activation
invasion
micromechanics
myelofibrosis
proliferation
Primary Myelofibrosis
spellingShingle TGF-β
fibroblast activation
invasion
micromechanics
myelofibrosis
proliferation
Primary Myelofibrosis
Teodorescu, Patric
Pasca, Sergiu
Jurj, Ancuta
Gafencu, Grigore
Joelsson, Jon-Petur
Selicean, Sonia
Moldovan, Cristian
Munteanu, Raluca
Onaciu, Anca
Tigu, Adrian-Bogdan
Buse, Mihail
Zimta, Alina-Andreea
Stiufiuc, Rares
Petrushev, Bobe
Desmirean, Minodora
Dima, Delia
Vlad, Cristina
Bergthorsson, Jon Thor
Berce, Cristian
Ciurea, Stefan
Ghiaur, Gabriel
Tomuleasa, Ciprian
Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
topic_facet TGF-β
fibroblast activation
invasion
micromechanics
myelofibrosis
proliferation
Primary Myelofibrosis
description To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download Primary myelofibrosis (PMF) is a Ph-negative myeloproliferative neoplasm (MPN), characterized by advanced bone marrow fibrosis and extramedullary haematopoiesis. The bone marrow fibrosis results from excessive proliferation of fibroblasts that are influenced by several cytokines in the microenvironment, of which transforming growth factor-β (TGF-β) is the most important. Micromechanics related to the niche has not yet been elucidated. In this study, we hypothesized that mechanical stress modulates TGF-β signalling leading to further activation and subsequent proliferation and invasion of bone marrow fibroblasts, thus showing the important role of micromechanics in the development and progression of PMF, both in the bone marrow and in extramedullary sites. Using three PMF-derived fibroblast cell lines and transforming growth factor-β receptor (TGFBR) 1 and 2 knock-down PMF-derived fibroblasts, we showed that mechanical stress does stimulate the collagen synthesis by the fibroblasts in patients with myelofibrosis, through the TGFBR1, which however seems to be activated through alternative pathways, other than TGFBR2. Keywords: TGF-β; fibroblast activation; invasion; micromechanics; myelofibrosis; proliferation. School of Doctoral Studies-Iuliu Hatieganu University Romanian Government Ion Chiricuta Oncology Institute Cluj Napoca international collaborative grant of the European Economic Space between Romania and Iceland 2020-2022 19
author2 1Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 2Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania. 3Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 4Molecular Haematology Unit - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. 5Stem Cell Research Unit, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland. 6Department of Laboratory Hematology, Landspitali University Hospital, Reykjavík, Iceland. 7Graduate School for Cellular and Biomedical Sciences, Universität Bern, Bern, Switzerland. 8Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 9Department of Pathology, Constantin Papilian Military Hospital, Cluj Napoca, Romania. 10Department of Hematology, Ion Chiricuta Clinical Research Center, Cluj Napoca, Romania. 11Department of Cardiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 12Department of Cardiology, Rehabilitation Hospital, Cluj Napoca, Romania. 13Department of Laboratory Hematology, Landspitali, University Hospital, Reykjavík, Iceland. 14Animal Facility, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 15Department of Cellular Therapies and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA. 16Department of Leukemia, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
format Article in Journal/Newspaper
author Teodorescu, Patric
Pasca, Sergiu
Jurj, Ancuta
Gafencu, Grigore
Joelsson, Jon-Petur
Selicean, Sonia
Moldovan, Cristian
Munteanu, Raluca
Onaciu, Anca
Tigu, Adrian-Bogdan
Buse, Mihail
Zimta, Alina-Andreea
Stiufiuc, Rares
Petrushev, Bobe
Desmirean, Minodora
Dima, Delia
Vlad, Cristina
Bergthorsson, Jon Thor
Berce, Cristian
Ciurea, Stefan
Ghiaur, Gabriel
Tomuleasa, Ciprian
author_facet Teodorescu, Patric
Pasca, Sergiu
Jurj, Ancuta
Gafencu, Grigore
Joelsson, Jon-Petur
Selicean, Sonia
Moldovan, Cristian
Munteanu, Raluca
Onaciu, Anca
Tigu, Adrian-Bogdan
Buse, Mihail
Zimta, Alina-Andreea
Stiufiuc, Rares
Petrushev, Bobe
Desmirean, Minodora
Dima, Delia
Vlad, Cristina
Bergthorsson, Jon Thor
Berce, Cristian
Ciurea, Stefan
Ghiaur, Gabriel
Tomuleasa, Ciprian
author_sort Teodorescu, Patric
title Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
title_short Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
title_full Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
title_fullStr Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
title_full_unstemmed Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
title_sort transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
publisher Wiley
publishDate 2020
url http://hdl.handle.net/2336/621564
https://doi.org/10.1111/jcmm.15526
genre Iceland
genre_facet Iceland
op_source Journal of cellular and molecular medicine
24
19
11100
11110
England
op_relation https://onlinelibrary.wiley.com/doi/10.1111/jcmm.15526
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576271/
Teodorescu P, Pasca S, Jurj A, Gafencu G, Joelsson JP, Selicean S, et al. Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis. J Cell Mol Med. 2020 Oct;24(19):11100-11110. doi:10.1111/jcmm.15526
32889753
doi:10.1111/jcmm.15526
http://hdl.handle.net/2336/621564
1582-4934
Journal of cellular and molecular medicine
op_rights © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Open Access - Opinn aðgangur
op_doi https://doi.org/10.1111/jcmm.15526
container_title Journal of Cellular and Molecular Medicine
container_volume 24
container_issue 19
container_start_page 11100
op_container_end_page 11110
_version_ 1766041318639796224
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/621564 2023-05-15T16:51:12+02:00 Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis. Teodorescu, Patric Pasca, Sergiu Jurj, Ancuta Gafencu, Grigore Joelsson, Jon-Petur Selicean, Sonia Moldovan, Cristian Munteanu, Raluca Onaciu, Anca Tigu, Adrian-Bogdan Buse, Mihail Zimta, Alina-Andreea Stiufiuc, Rares Petrushev, Bobe Desmirean, Minodora Dima, Delia Vlad, Cristina Bergthorsson, Jon Thor Berce, Cristian Ciurea, Stefan Ghiaur, Gabriel Tomuleasa, Ciprian 1Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 2Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania. 3Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 4Molecular Haematology Unit - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. 5Stem Cell Research Unit, Biomedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland. 6Department of Laboratory Hematology, Landspitali University Hospital, Reykjavík, Iceland. 7Graduate School for Cellular and Biomedical Sciences, Universität Bern, Bern, Switzerland. 8Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 9Department of Pathology, Constantin Papilian Military Hospital, Cluj Napoca, Romania. 10Department of Hematology, Ion Chiricuta Clinical Research Center, Cluj Napoca, Romania. 11Department of Cardiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 12Department of Cardiology, Rehabilitation Hospital, Cluj Napoca, Romania. 13Department of Laboratory Hematology, Landspitali, University Hospital, Reykjavík, Iceland. 14Animal Facility, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. 15Department of Cellular Therapies and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA. 16Department of Leukemia, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2020-11 http://hdl.handle.net/2336/621564 https://doi.org/10.1111/jcmm.15526 en eng Wiley https://onlinelibrary.wiley.com/doi/10.1111/jcmm.15526 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576271/ Teodorescu P, Pasca S, Jurj A, Gafencu G, Joelsson JP, Selicean S, et al. Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis. J Cell Mol Med. 2020 Oct;24(19):11100-11110. doi:10.1111/jcmm.15526 32889753 doi:10.1111/jcmm.15526 http://hdl.handle.net/2336/621564 1582-4934 Journal of cellular and molecular medicine © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. Open Access - Opinn aðgangur Journal of cellular and molecular medicine 24 19 11100 11110 England TGF-β fibroblast activation invasion micromechanics myelofibrosis proliferation Primary Myelofibrosis Article 2020 ftlandspitaliuni https://doi.org/10.1111/jcmm.15526 2022-05-29T08:22:35Z To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download Primary myelofibrosis (PMF) is a Ph-negative myeloproliferative neoplasm (MPN), characterized by advanced bone marrow fibrosis and extramedullary haematopoiesis. The bone marrow fibrosis results from excessive proliferation of fibroblasts that are influenced by several cytokines in the microenvironment, of which transforming growth factor-β (TGF-β) is the most important. Micromechanics related to the niche has not yet been elucidated. In this study, we hypothesized that mechanical stress modulates TGF-β signalling leading to further activation and subsequent proliferation and invasion of bone marrow fibroblasts, thus showing the important role of micromechanics in the development and progression of PMF, both in the bone marrow and in extramedullary sites. Using three PMF-derived fibroblast cell lines and transforming growth factor-β receptor (TGFBR) 1 and 2 knock-down PMF-derived fibroblasts, we showed that mechanical stress does stimulate the collagen synthesis by the fibroblasts in patients with myelofibrosis, through the TGFBR1, which however seems to be activated through alternative pathways, other than TGFBR2. Keywords: TGF-β; fibroblast activation; invasion; micromechanics; myelofibrosis; proliferation. School of Doctoral Studies-Iuliu Hatieganu University Romanian Government Ion Chiricuta Oncology Institute Cluj Napoca international collaborative grant of the European Economic Space between Romania and Iceland 2020-2022 19 Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Journal of Cellular and Molecular Medicine 24 19 11100 11110